Effects of tumor necrosis factor alpha blocker adalimumab in experimental spinal cord injury

Journal of Korean Neurosurgical Society
Alp Özgün BörcekÖzlem Gülbahar

Abstract

Tumor necrosis factor alpha (TNF-α) have proven effects in pathogenesis of neuroinflammation after spinal cord injury (SCI). Current study is designed to evaluate the effects of an anti-TNF-α agent, adalimumab, on spinal cord clip compression injury in rats. Thirty two male adult Wistar rats were divided into four groups (sham, trauma, infliximab, and adalimumab groups) and SCI was introduced using an aneurysm clip. Animals in treatment groups received 5 mg/kg subcutaneous adalimumab and infliximab right after the trauma. Malondialdehyde (MDA) levels were studied in traumatized spinal cord tissues 72 hours after the injury as a marker of lipid peroxidation. Animals that received anti-TNF-α agents are found to have significantly decreased MDA levels. MDA levels were significantly different between the trauma and infliximab groups (p<0.01) and trauma and adalimumab groups (p=0.022). There was no significant difference in neurological evaluation of the rats using Tarlov scale. These results suggest that, like infliximab, adalimumab has favorable effects on lipid peroxidation induced by spinal cord trauma in rats.

References

May 1, 1978·Analytical Biochemistry·M Mihara, M Uchiyama
Dec 1, 1971·Journal of Neurosurgery·T B DuckerL G Kempf
Jan 6, 1984·JAMA : the Journal of the American Medical Association·M B BrackenP L Perot
Sep 1, 1996·Journal of Neuroimmunology·C X WangJ Gybels
Jun 6, 1998·Experimental Neurology·S L CarlsonL Dossett
Nov 21, 2002·Progress in Brain Research·Michael S BeattieJacqueline C Bresnahan
Aug 9, 2005·Journal of Neurotrauma·J Frederick HarringtonAdam Chodobski
Dec 13, 2005·The Journal of Surgical Research·John C PapakostasAngelos M Kappas
Oct 31, 2006·Brain : a Journal of Neurology·Jennifer C FlemingLynne C Weaver
Apr 29, 2008·Surgical Neurology·Gökhan KurtNecdet Ceviker
Feb 4, 2009·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Zehra KaymakcalanEric H Sasso
Sep 8, 2010·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Cagatay GuvenNecdet Ceviker
Oct 12, 2010·World Neurosurgery·Hakan EmmezAydin Paşaoğlu
Apr 9, 2011·Journal of Neuroimmunology·Ana CamineroXavier Montalban
Apr 25, 2012·European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·Fatih BayrakliHamit Zafer Kars
Jun 28, 2012·Journal of Korean Neurosurgical Society·Song-Hee YuJoo-Kyung Sung
Mar 13, 2013·Molecular and Cellular Biochemistry·Xin TangXiaosong Gu
Apr 13, 2013·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Celeste B Burness, Gillian M Keating

❮ Previous
Next ❯

Citations

Nov 13, 2019·Journal of Biomolecular Structure & Dynamics·Mallikarjuna NimgampalleVasudharani Devanathan

❮ Previous
Next ❯

Methods Mentioned

BETA
MDA

Software Mentioned

SPSS

Related Concepts

Related Feeds

Aneurysm

Aneurysms are outward distensions or bulges that occurs in a weakened wall of blood vessels. Discover the latest research on aneurysms here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Related Papers

Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
Cagatay GuvenNecdet Ceviker
The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology
Ebru MenekseÖmer Cengiz
© 2022 Meta ULC. All rights reserved